Efficacy of bi-weekly docetaxel in hormone-sensitive metastatic prostate cancer (mHSPC).

被引：0
|
作者：
Lombana Quinonez, Milton Alberto
Milena Torres, Ana
Gonzalez, Guido
机构：
[1] Ctr Integral Canc Clin Occidente, Cali, Colombia
[2] Nalt Med Solut, Cali, Colombia
[3] Clin Occidente, Cali, Colombia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17070
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Rezvilutamide for metastatic hormone-sensitive prostate cancer
    Singh, Kirti
    Mandal, Swarnendu
    Nayak, Prasant
    Das, Manoj
    Tripathy, Sambit
    LANCET ONCOLOGY, 2022, 23 (11): : E490 - E490
  • [42] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [43] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Brandon Bernard
    Christopher J. Sweeney
    Current Urology Reports, 2015, 16
  • [44] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +
  • [45] Update on Metastatic Hormone-Sensitive Prostate Cancer
    Chi, Kim N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 277 - 280
  • [46] QUALITATIVE EXPLORATION OF THE REAL-WORLD EXPERIENCES OF MEN RECEIVING OR REFUSING CHEMOTHERAPY (DOCETAXEL) FOR THE TREATMENT OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)
    Ito, T.
    Grant, L.
    Mills, A.
    Heselwood, A.
    Gater, A.
    VALUE IN HEALTH, 2017, 20 (09) : A450 - A450
  • [47] Indirect comparison of abiraterone acetate and docetaxel for treatment of metastatic "hormone-sensitive" prostate cancer
    Feyerabend, S.
    Saad, F.
    Li, T.
    Ito, T.
    Diels, J.
    Van Sanden, S.
    De Porre, P.
    Roiz, J.
    Abogunrin, S.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation model
    Hird, Amanda E.
    Magee, Diana E.
    Cheung, Douglas C.
    Matta, Rano
    Kulkarni, Girish S.
    Nam, Robert K.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (09): : E418 - E427
  • [49] Pros and cons of docetaxel used to treat metastatic hormone-sensitive prostate cancer: The cons
    Suzuki, Kazuhiro
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Tumour suppressor gene signature predicts early progression in metastatic hormone-sensitive metastatic prostate cancer (mHSPC) patients
    Garcia De Herreros, M.
    Jimenez Blasco, N.
    Reig Torras, O.
    Ferrer Mileo, L.
    Aversa, C.
    Garcia-Esteve, S.
    Rodriguez-Carunchio, L.
    Trias Puigsureda, I.
    Padrosa, J.
    Fernandez Manas, L.
    Marin, M.
    Font Pous, A.
    Rodriguez-Vida, A.
    Climent Duran, M. A.
    Cros Costa, S.
    Chirivella Gonzalez, I.
    Figols Gorina, M.
    Mellado Gonzalez, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S992 - S992
12345